143 Gardner Road
Brookline, MA 02445
Full Time Employees:
|Mr. Wayne Smith||Chief Financial Officer, Sec., Treasurer and Director||20.96k||N/A||1957|
|Dr. Elliot Lebowitz Ph.D.||Chief Exec. Officer, Pres and Director||N/A||N/A||1942|
Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.
Xeno Transplants Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.